Entity family

Browse treatments

Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.

7,227articles mentioning treatments

16,644treatment mentions

4,719distinct treatments extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

All extracted treatments

Showing 3,781–3,840 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.

local anesthetic infusion1 local anesthetic reversal1 local anesthetic wound infiltration1 local boost1 local infiltration anaesthesia1 local injections1 local radiotherapy1 localized thoracic radiotherapy1 locoregional treatments1 logic-gated Tmod chimeric antigen receptor T-cell therapies1 logotherapy1 long term haemodialysis1 long term treatment1 long-term antibiotic therapies1 long-term macrolide therapy1 long-term non-invasive ventilation1 long-term positive pressure ventilation1 low anterior resection1 low-carbohydrate diet1 low-concentrate platelet-rich plasma injections1 low-density lipoprotein (LDL)-lowering treatment1 low-dose CT1 low-dose corticotherapy1 low-dose rate brachytherapy1 low-dose steroids1 low-efficacy therapy1 low-field MRI1 low-intensity focused ultrasound1 low-volume superior trunk block1 lower limb strengthening programme1 lower limb surgery1 lumbar decompression1 lumbar sympathetic block1 lung protective ventilation strategies1 lung resection1 lung transplant1 lymph node biopsy1 lymph node resection1 lysine-reduction treatment1 maintenance and reliever therapy1 maintenance and reliever therapy regimens1 maintenance renal replacement therapy1 maintenance treatment1 major lower limb amputation1 major surgery1 malaria prophylaxis1 management course1 mandibular advancement devices1 mannose-based diet1 manual acupuncture1 manual therapies1 marital therapy1 masculinising chest surgery1 mask1 masking and retraining therapy1 mast cell stabilisation therapy1 mastectomies1 maxillary nerve block1 mechanic trombectomy1 mechanical cardiac support1

View all 4,719 treatments on one page

Articles mentioning treatments

7,227 articles · page 229 of 603

1286 Developing patient-derived tumor organoid model for drug test in Vietnamese setting

jitc · abstract · 2025-11-04 · 2 matching annotations

86.3%

FOLFOX FOLFIRI 5-FU oxaliplatin irinotecan CRC colorectal cancer

… differential treatment responses (figure 3):First-line therapy FOLFOX: tumor progression in metastatic lesions.Second-line therapy FO…

131 Combining high-plex proteomics with single-cell transcriptomics for deep characterization of antigen-specific T cell responses

jitc · abstract · 2025-11-04 · 2 matching annotations

87.4%

cancer vaccines immune checkpoint inhibitors COVID-19 CellCarta Olink Reveal 10x Genomics

…apies, such as immune checkpoint inhibitors, CAR-T cells, TILs, cancer vaccines, and T cell engagers/redirectors, work by inducing a robust T c…

155 NGS-Based identity testing and biosafety assessment for cell therapy products

jitc · abstract · 2025-11-04 · 2 matching annotations

88.8%

cancer treatment FDA International Council for Harmonisation FDA-recommended

…he development and quality control of cell therapy products for cancer treatment. As advanced therapies expand into clinical oncology, there is …

192 Development of the proteogenomic antibody repertoire assay for anti-tumor antibody discovery

jitc · abstract · 2025-11-04 · 2 matching annotations

81.1%

radioimmunotherapies chimeric antigen receptor (CAR)-T cell therapies cancer OSU cohort3

…ntibodies (mAbs), antibody-drug conjugates (ADCs), bispecifics, radioimmunotherapies, and chimeric antigen receptor (CAR)-T cell therapies. 1 Howeve…

193 Exploratory analyses from the Ph2 window of opportunity study ASP-1929-103 shows induction of an inflammatory response by ASP-1929 photoimmunotherapy in operable primary or recurrent HNSCC and cuSCC

jitc · abstract · 2025-11-04 · 2 matching annotations

77.2%

ASP-1929 PIT HNSCC cuSCC Pembrolizumab National Institutes of Health IRDye®700DX ASP-1929 NIH

…s Across Patients Show Consistent Immune Cell Changes Following ASP-1929 PIT. Uniform Manifold Approximation and Projection (UMAP) plot show…

197 Enhanced anti-tumor efficacy and safety of dual-targeting tandem PD-L1 and EphA2 CAR-T cells in solid tumor models

jitc · abstract · 2025-11-04 · 2 matching annotations

84.0%

CAR-T therapy Solid tumors PD-L1-EphA2-4-1BB PD-L1-EphA2-CD28 EphA2-PD-L1-4-1BB PD-L1-EphA2 EphA2-PD-L1-CD28

…findings support the clinical development of PD-L1-EphA2 tandem CAR-T therapy for treating solid tumors expressing either or both antigens, a…

249 CD3ε enhances CAR-T fitness and persistence by promoting the survival of effector memory T cells

jitc · abstract · 2025-11-04 · 2 matching annotations

82.4%

CAR-T therapy CAR-T Cell Therapy B-cell malignancies AAALAC-approved facility CAR-T

…Background CAR-T therapy has demonstrated potent anti-tumor efficacy in treating a range…

262 Tuning CAR-T cells by targeting cancer-associated glycan in pancreatic cancer

jitc · abstract · 2025-11-04 · 2 matching annotations

84.6%

CAR-T cell therapy CAR T cell therapy Pancreatic Ductal Adenocarcinoma pancreatic cancer Mass General Brigham solid tumors MGH Cancer Center American-Italian Cancer Foundation CRIS Foundation Out-Back Fellowship Programme rotein+2 more

…Background CAR-T cell therapy has shown limited efficacy in solid tumors due to factors such …

272 Moderating regulatory T cell brakes in CAR T cell immunotherapy of solid tumors through the CD4-CD28 co-stimulation axis

jitc · abstract · 2025-11-04 · 2 matching annotations

87.4%

CAR-T cell immunotherapies CAR T cell immunotherapies solid tumors

…Background CAR-T cell immunotherapies are being avidly pursued for treatment of solid tumors. However…

274 Comprehensive spatial immune profiling of pediatric NUT carcinoma identifies novel prognostic signatures and B7-H3 as a target for CAR-T cell therapy

jitc · abstract · 2025-11-04 · 2 matching annotations

80.7%

immune checkpoint blockade standard treatments University Hospital Tübingen German Cancer Research Center NUT carcinoma B7-H3 NGS Core Facility Omics IT and Data Management Core Facility DKFZ B7-H3-targeted

…nreported immunologically ‘hot’ NC tumors that may benefit from immune checkpoint blockade and other immunotherapies. To uncover novel actionable targets …

277 Proteome turnover dynamics analysis uncovers E3 ligases that enhance T-cell persistence during exhaustion

jitc · abstract · 2025-11-04 · 2 matching annotations

80.5%

ACT solid tumors hematologic cancers metastatic melanoma RNF166

…highlighting a promising strategy for improving the efficacy of ACT.Abstract 277 Figure 1Comprehensive analysis of proteome turnove…

2 CD34 huNSG-FLT3-IL15, a novel mouse strain with improved development of T, myeloid, dendritic, and natural killer cells for immuno-oncology therapeutic applications

jitc · abstract · 2025-11-04 · 2 matching annotations

77.8%

Trispecific NK cell engagers antibody-drug conjugates University of Minnesota cancer Jackson Laboratory human IL-15

…umors and evaluated against various IO therapies such as CAR T, Trispecific NK cell engagers, and antibody-drug conjugates.Results CD34 NSG-FLT3-IL15 mice e…